B
Bartlomiej Zych
Researcher at Harefield Hospital
Publications - 79
Citations - 1509
Bartlomiej Zych is an academic researcher from Harefield Hospital. The author has contributed to research in topics: Lung transplantation & Transplantation. The author has an hindex of 20, co-authored 77 publications receiving 1289 citations.
Papers
More filters
Journal ArticleDOI
Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning.
Bartlomiej Zych,Aron Frederik Popov,George Stavri,Alison Bashford,Toufan Bahrami,Mohamed Amrani,Fabio De Robertis,Martin Carby,Nandor Marczin,Nandor Marczin,Andre R. Simon,Karen C. Redmond +11 more
TL;DR: Evaluated ex vivo lung perfusion may facilitate assessment and/or reconditioning of borderline lungs, with a conversion rate of 46 % and good short-term survival.
Journal ArticleDOI
Evaluation of the Organ Care System in Heart Transplantation With an Adverse Donor/Recipient Profile
Diana García Sáez,Bartlomiej Zych,Anton Sabashnikov,Christopher T. Bowles,Fabio De Robertis,Prashant N. Mohite,Aron-Frederik Popov,Olaf Maunz,Nikhil P. Patil,Alexander Weymann,T. Pitt,Louise McBrearty,Bradley Pates,R. Hards,Mohamed Amrani,Toufan Bahrami,Nicholas R. Banner,Andre R. Simon +17 more
TL;DR: Use of the TransMedics Organ Care System is associated with markedly improved short-term outcomes and transplant activity by allowing use of organs previously not considered suitable for transplantation or selection of higher risk recipients, or both.
Journal ArticleDOI
Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis.
Dustin Krutsinger,Robert M. Reed,Amy E. Blevins,Varun Puri,Nilto C. De Oliveira,Bartlomiej Zych,Servet Bölükbas,Dirk Van Raemdonck,Gregory I Snell,Michael Eberlein +9 more
TL;DR: Survival after LTx from DCD is comparable to survival afterLTx from DBD in observational cohort studies, and DCD appears to be a safe and effective method to expand the donor pool.
Journal ArticleDOI
HeartWare left ventricular assist device implantation through bilateral anterior thoracotomy.
Aron Frederik Popov,Morteza Tavakkoli Hosseini,Bartlomiej Zych,Andre R. Simon,Toufan Bahrami +4 more
TL;DR: The technique for HeartWare LVAD implantation through bilateral anterior thoracotomy incisions is presented, which has proved to be safe and reproducible, with good clinical outcome.
Journal ArticleDOI
Clinical Experience With HeartWare Left Ventricular Assist Device in Patients With End-Stage Heart Failure
Aron Frederik Popov,Morteza Tavakkoli Hosseini,Bartlomiej Zych,Prashant N. Mohite,R. Hards,Heike Krueger,Toufan Bahrami,Mohamed Amrani,Andre R. Simon +8 more
TL;DR: Although cardiac transplantation remains the gold standard for treatment of end-stage heart failure patients, the HeartWare VAD can be used as a safe alternative with a satisfactory clinical outcome.